Tag: Intismeran Autogene

Personalised mRNA Cancer Vaccine Clears Major Phase-3 Milestone in Melanoma: How Is It Different From Vaccines That Prevent Disease?

A personalised mRNA cancer vaccine from Moderna and Merck has reached a major Phase 3 milestone in melanoma. Intismeran autogene, combined with Keytruda, improved recurrence-free and distant metastasis-free survival, although the treatment remains investigational and is not yet approved.